ALACOVID Study for Vaccinated Subjects

NACompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

March 15, 2022

Primary Completion Date

June 18, 2022

Study Completion Date

June 18, 2022

Conditions
COVID-19 Respiratory Infection
Interventions
DRUG

150 mg 5-ALAPhosphate + SFC

2 capsules in the morning after breakfast (before 11 AM) and 1 capsule in the evening after a snack or after dinner (before 8 PM) orally with water for 21 days.

OTHER

Placebo

No Description for the intervention

Trial Locations (4)

302017

JNU Institute for Medical Sciences and Research Centre, Jaipur

411037

Ranka Hospital, Pune

421203

BAJ RR Hospital and Research Centre, Dombivali

422005

Leelawati Care Hospital-Nasik (SMO), Nashik

All Listed Sponsors
lead

Vedic Lifesciences Pvt. Ltd.

INDUSTRY